{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:33:40Z","timestamp":1788878020778,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1842,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013101","name":"National Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.virol.2008.04.003","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T04:09:40Z","timestamp":1210824580000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine"],"prefix":"10.1016","volume":"377","author":[{"given":"Joseph W.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.virol.2008.04.003_bib1","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/JVI.79.10.6260-6271.2005","article-title":"Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R","volume":"79","author":"Aldaz-Carroll","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2005.07.006","article-title":"Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene","volume":"341","author":"Aldaz-Carroll","year":"2005","journal-title":"Virology"},{"issue":"15","key":"10.1016\/j.virol.2008.04.003_bib3","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1128\/JVI.00374-07","article-title":"Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6","volume":"81","author":"Aldaz-Carroll","year":"2007","journal-title":"J. Virol."},{"issue":"25","key":"10.1016\/j.virol.2008.04.003_bib4","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2005.01.079","article-title":"A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults","volume":"23","author":"Artenstein","year":"2005","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.virol.2008.04.003_bib5","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/jvi.67.6.3319-3325.1993","article-title":"Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene","volume":"67","author":"Blasco","year":"1993","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2008.04.003_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(03)00008-1","article-title":"Pathogenesis and potential antiviral therapy of complications of smallpox vaccination","volume":"58","author":"Bray","year":"2003","journal-title":"Antivir. Res"},{"issue":"6","key":"10.1016\/j.virol.2008.04.003_bib7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/381976","article-title":"Looking back at smallpox","volume":"38","author":"Bray","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.virol.2008.04.003_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2003.11.053","article-title":"Smallpox vaccination and myopericarditis: a clinical review","volume":"43","author":"Cassimatis","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"10.1016\/j.virol.2008.04.003_bib9","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1128\/JVI.00906-07","article-title":"Characterization of chimpanzee\/human monoclonal antibodies to the vaccinia A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia mouse protection model","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2004.05.004","article-title":"Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination","volume":"44","author":"Eckart","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.virol.2008.04.003_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"issue":"5672","key":"10.1016\/j.virol.2008.04.003_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.304.5672.809a","article-title":"Biodefense smallpox vaccines: looking beyond the next generation","volume":"304","author":"Enserink","year":"2004","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virol.2005.09.056","article-title":"Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host","volume":"345","author":"Fang","year":"2006","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.virol.2008.04.003_bib15","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virol.2008.04.003_bib16","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.vaccine.2006.12.037","article-title":"Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges","volume":"25","author":"Fogg","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2008.04.003_bib19","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2008.04.003_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.04.003_bib22","series-title":"Prophylactic and Therapeutic Monoclonal Antibodies. The United States of America as represented by the Secretary of the Army","author":"Hooper","year":"2002"},{"issue":"9","key":"10.1016\/j.virol.2008.04.003_bib23","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2008.04.003_bib24","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.vaccine.2006.11.017","article-title":"Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge","volume":"25","author":"Hooper","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.virol.2008.04.003_bib26","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1371\/journal.pmed.0030272","article-title":"Frequency of adverse events after vaccination with different vaccinia strains","volume":"3","author":"Kretzschmar","year":"2006","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.virol.2008.04.003_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1045-1870(03)00032-3","article-title":"Adverse events occurring after smallpox vaccination","volume":"14","author":"Lane","year":"2003","journal-title":"Semin. Pediatr. Infect. Dis."},{"issue":"Pt 1","key":"10.1016\/j.virol.2008.04.003_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1099\/0022-1317-83-1-209","article-title":"Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread","volume":"83","author":"Law","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2004.07.024","article-title":"Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement","volume":"328","author":"Lustig","year":"2004","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.virol.2008.04.003_bib31","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"issue":"Suppl 2,","key":"10.1016\/j.virol.2008.04.003_bib32","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ijid.2004.09.002","article-title":"ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)\u2014a second-generation smallpox vaccine for biological defense","volume":"8","author":"Monath","year":"2004","journal-title":"Int. J. Infect. Dis."},{"issue":"9508","key":"10.1016\/j.virol.2008.04.003_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(06)68143-9","article-title":"Smallpox","volume":"367","author":"Moore","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2008.04.003_bib34","series-title":"Fields Virology","first-page":"1249","article-title":"Poxviruses and their replication","author":"Moss","year":"2001"},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2005.09.037","article-title":"Poxvirus entry and membrane fusion","volume":"344","author":"Moss","year":"2006","journal-title":"Virology"},{"issue":"36","key":"10.1016\/j.virol.2008.04.003_bib37","doi-asserted-by":"crossref","first-page":"12921","DOI":"10.1073\/pnas.0505180102","article-title":"Interferon function is not required for recovery from a secondary poxvirus infection","volume":"102","author":"Panchanathan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.virol.2008.04.003_bib38","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/JVI.00115-06","article-title":"Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function","volume":"80","author":"Panchanathan","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.icb.7100118","article-title":"Correlates of protective immunity in poxvirus infection: where does antibody stand?","volume":"86","author":"Panchanathan","year":"2008","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.virol.2008.04.003_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease","volume":"2","author":"Parker","year":"2007","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/jvi.31.1.147-155.1979","article-title":"Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus","volume":"31","author":"Payne","year":"1979","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virol.2008.04.003_bib42","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.1128\/JVI.00598-06","article-title":"Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins","volume":"80","author":"Perdiguero","year":"2006","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2008.04.003_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2006.08.025","article-title":"Protein composition of the vaccinia virus mature virion","volume":"358","author":"Resch","year":"2007","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2008.04.003_bib45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3201\/eid1306.061540","article-title":"Endemic human monkeypox, Democratic Republic of Congo, 2001\u20132004","volume":"13","author":"Rimoin","year":"2007","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2008.04.003_bib46","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/jvi.70.6.3753-3762.1996","article-title":"Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene","volume":"70","author":"Roper","year":"1996","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2008.04.003_bib47","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/JVI.72.5.4192-4204.1998","article-title":"The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus","volume":"72","author":"Roper","year":"1998","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.virol.2008.04.003_bib48","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JVI.73.4.2863-2875.1999","article-title":"Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation","volume":"73","author":"Rottger","year":"1999","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2008.04.003_bib49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib50","first-page":"89","article-title":"Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens","volume":"37","author":"Sakhatskyy","year":"2008","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.virol.2008.04.003_bib51","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1128\/jvi.71.12.9563-9569.1997","article-title":"Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge","volume":"71","author":"Schmaljohn","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.04.003_bib52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-4615-5331-1_51","article-title":"Extracellular enveloped vaccinia virus entry, egress, and evasion","volume":"440","author":"Smith","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"issue":"Pt 12","key":"10.1016\/j.virol.2008.04.003_bib53","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2008.04.003_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","article-title":"Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein","volume":"368","author":"Su","year":"2007","journal-title":"Virology"},{"issue":"Pt 8","key":"10.1016\/j.virol.2008.04.003_bib55","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1099\/0022-1317-78-8-2041","article-title":"Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation","volume":"78","author":"Vanderplasschen","year":"1997","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.virol.2008.04.003_bib56","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/jvi.71.5.4032-4041.1997","article-title":"A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors","volume":"71","author":"Vanderplasschen","year":"1997","journal-title":"J. Virol."},{"issue":"RR\u20137","key":"10.1016\/j.virol.2008.04.003_bib57","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"Morb. Mort. Wkly. Rep., Recomm. Rep."},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2008.04.003_bib59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/JVI.75.1.303-310.2001","article-title":"The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein","volume":"75","author":"Wolffe","year":"2001","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2008.04.003_bib60","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2003.07.001","article-title":"Viral infections in atopic dermatitis: pathogenic aspects and clinical management","volume":"112","author":"Wollenberg","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.virol.2008.04.003_bib61","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2006.10.009","article-title":"A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost","volume":"25","author":"Xiao","year":"2007","journal-title":"Vaccine"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682208002134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682208002134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:53:55Z","timestamp":1758585235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682208002134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0042682208002134"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2008.04.003","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2008.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}